Issue 2-3/2009
Catastrophic Antiphospholipid Syndrome and Related Autoimmune Cardiovascular Manifestations
Content (14 Articles)
Clinical and Laboratory Features of the Catastrophic Antiphospholipid Syndrome
Ljudmila Stojanovich, Dragomir Marisavljevic, Jozef Rovensky, Aleksandra Djokovich, Darina Kozáková, Nikola Milinic
Catastrophic Antiphospholipid Syndrome: Treatment, Prognosis, and the Risk of Relapse
Silvia Bucciarelli, Doruk Erkan, Gerard Espinosa, Ricard Cervera
Pregnancy and Catastrophic Antiphospholipid Syndrome
Jose A. Gómez-Puerta, Jose Sanin-Blair, Claudio Galarza-Maldonado
Infections and the Antiphospholipid Syndrome
Mario García-Carrasco, Claudio Galarza-Maldonado, Claudia Mendoza-Pinto, Ricardo O. Escarcega, Ricard Cervera
Microthrombotic/Microangiopathic Manifestations of the Antiphospholipid Syndrome
Sonja Praprotnik, Dušan Ferluga, Alenka Vizjak, Anastazija Hvala, Tadej Avčin, Blaž Rozman
Revisiting Libman–Sacks Endocarditis: A Historical Review and Update
Jennifer L. Lee, Stanley M. Naguwa, Gurtej S. Cheema, M. Eric Gershwin
The Role of Complement in the Antiphospholipid Syndrome-Associated Pathology
Ingrid Avalos, George C. Tsokos
Plasma Homocysteine Levels, The Prevalence of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Macrovascular Disorders in Systemic Sclerosis: Risk Factors for Accelerated Macrovascular Damage?
Szilvia Szamosi, Zoltán Csiki, Edit Szomják, Erzsébet Szolnoki, Gabriella Szőke, Zoltán Szekanecz, Gyula Szegedi, Yehuda Shoenfeld, Gabriella Szűcs
Recent Advances in the Treatment of Systemic Sclerosis
Vasiliki Kalliopi K. Bournia, Panayiotis G. Vlachoyiannopoulos, Carlo Selmi, Haralampos M. Moutsopoulos, M. Eric Gershwin